Cite
HARVARD Citation
Li, J. et al. (2021). Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis. Expert opinion on investigational drugs. pp. 923-930. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, J. et al. (2021). Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis. Expert opinion on investigational drugs. pp. 923-930. [Online].